Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003060 |
---|---|
Receipt number | R000003714 |
Scientific Title | Phase II clinical trial of personalized peptide vaccination for sarcoma patients |
Date of disclosure of the study information | 2010/01/19 |
Last modified on | 2019/10/30 13:29:23 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/01/19 19:08:48 | ||
2 | Update | 2010/01/25 10:38:23 | Key inclusion criteria |
|
3 | Update | 2010/07/16 14:34:43 | Organization1 Address1 Tel1 Email1 |
|
4 | Update | 2014/07/10 15:50:29 | Division name Division name Address Address TEL Institute Institute Organization Organization Category of Funding Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
5 | Update | 2014/12/12 11:53:53 | Key secondary outcomes |
|
6 | Update | 2014/12/12 11:55:23 | Interventions/Control_1 Key inclusion criteria Key inclusion criteria |
|
7 | Update | 2019/01/07 10:56:24 | Recruitment status |
|
8 | Update | 2019/10/30 13:29:23 | Recruitment status Date of IRB Last follow-up date |